Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Cadence Pharmaceuticals, Inc. (NASDAQ:CADX.DL)

CAPS Rating: No stars

A biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:CADX.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.75)
Submitted August 23, 2013

I think Cadence stock may have stabilized from the double whammy of concerns over Ofirmev profitability and potentially gaping holes in IP protection. While Ofirmev hasn;t had the launch of the century, it's still doing better than I expected with… More

NetscribeBiotech (78.69)
Submitted March 22, 2007

Cadence Pharmaceuticals, Inc. (Cadence) is a biopharmaceutical company focused on in licensing, developing and ultimately commercializing its product candidates principally for use in the hospital setting. The company had in-licensed rights to two… More

NASDAQ:CADX.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about CADX.DL.

No one has written a Pitch for CADX.DL stock yet. Tell us why you think CADX.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in CADX.DL.

No players have picked CADX.DL yet. Tell us why you think CADX.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CADX.DL.